{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Pargyline : Questions médicales les plus fréquentes",
"headline": "Pargyline : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Pargyline : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-21",
"dateModified": "2026-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Pargyline"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Benzylamines",
"url": "https://questionsmedicales.fr/mesh/D001596",
"about": {
"@type": "MedicalCondition",
"name": "Benzylamines",
"code": {
"@type": "MedicalCode",
"code": "D001596",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.140.210"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Pargyline",
"alternateName": "Pargyline",
"code": {
"@type": "MedicalCode",
"code": "D010293",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "E A Kulikova",
"url": "https://questionsmedicales.fr/author/E%20A%20Kulikova",
"affiliation": {
"@type": "Organization",
"name": "Federal research center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090 Russia."
}
},
{
"@type": "Person",
"name": "D V Fursenko",
"url": "https://questionsmedicales.fr/author/D%20V%20Fursenko",
"affiliation": {
"@type": "Organization",
"name": "Federal research center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090 Russia."
}
},
{
"@type": "Person",
"name": "E Yu Bazhenova",
"url": "https://questionsmedicales.fr/author/E%20Yu%20Bazhenova",
"affiliation": {
"@type": "Organization",
"name": "Federal research center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090 Russia."
}
},
{
"@type": "Person",
"name": "A V Kulikov",
"url": "https://questionsmedicales.fr/author/A%20V%20Kulikov",
"affiliation": {
"@type": "Organization",
"name": "Federal research center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090 Russia."
}
},
{
"@type": "Person",
"name": "Qiu-Qin Huang",
"url": "https://questionsmedicales.fr/author/Qiu-Qin%20Huang",
"affiliation": {
"@type": "Organization",
"name": "MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, Fujian Provincial Key Laboratory of Electrochemical Energy Storage Materials, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China. qhw76@fzu.edu.cn."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Biology System Description Language (BiSDL): a modeling language for the design of multicellular synthetic biological systems.",
"datePublished": "2024-04-25",
"url": "https://questionsmedicales.fr/article/38664639",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12859-024-05782-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Language models for biological research: a primer.",
"datePublished": "2024-08-09",
"url": "https://questionsmedicales.fr/article/39122951",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41592-024-02354-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Computational theories should be made with natural language instead of meaningless code.",
"datePublished": "2023-10-10",
"url": "https://questionsmedicales.fr/article/37813403",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/S0140525X23001231"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sapporo: A workflow execution service that encourages the reuse of workflows in various languages in bioinformatics.",
"datePublished": "2024-06-24",
"url": "https://questionsmedicales.fr/article/39070189",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12688/f1000research.122924.2"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Generic Transformation Approach for Complex Laboratory Data Using the Fast Healthcare Interoperability Resources Mapping Language: Method Development and Implementation.",
"datePublished": "2024-10-18",
"url": "https://questionsmedicales.fr/article/39423342",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/57569"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composés benzyliques",
"item": "https://questionsmedicales.fr/mesh/D001593"
},
{
"@type": "ListItem",
"position": 8,
"name": "Benzylamines",
"item": "https://questionsmedicales.fr/mesh/D001596"
},
{
"@type": "ListItem",
"position": 9,
"name": "Pargyline",
"item": "https://questionsmedicales.fr/mesh/D010293"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Pargyline - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Pargyline",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-06-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Pargyline",
"description": "Comment diagnostiquer une surdose de pargyline ?\nQuels tests sont utilisés pour évaluer l'effet de la pargyline ?\nQuels symptômes indiquent un besoin de pargyline ?\nComment évaluer l'efficacité de la pargyline ?\nQuels signes cliniques nécessitent un ajustement de dose ?",
"url": "https://questionsmedicales.fr/mesh/D010293?mesh_terms=Programming+Languages#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Pargyline",
"description": "Quels sont les effets secondaires courants de la pargyline ?\nLa pargyline peut-elle causer des troubles du sommeil ?\nQuels symptômes indiquent une réaction allergique à la pargyline ?\nLa pargyline peut-elle provoquer des palpitations ?\nQuels symptômes nécessitent une consultation médicale urgente ?",
"url": "https://questionsmedicales.fr/mesh/D010293?mesh_terms=Programming+Languages#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Pargyline",
"description": "Comment prévenir les effets secondaires de la pargyline ?\nQuelles précautions prendre avant de commencer la pargyline ?\nLa pargyline nécessite-t-elle un régime alimentaire particulier ?\nComment éviter les interactions médicamenteuses avec la pargyline ?\nQuels conseils donner aux patients sous pargyline ?",
"url": "https://questionsmedicales.fr/mesh/D010293?mesh_terms=Programming+Languages#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Pargyline",
"description": "Comment la pargyline est-elle administrée ?\nLa pargyline peut-elle être combinée avec d'autres médicaments ?\nQuel est le dosage habituel de pargyline ?\nQuels sont les traitements alternatifs à la pargyline ?\nComment surveiller les effets de la pargyline ?",
"url": "https://questionsmedicales.fr/mesh/D010293?mesh_terms=Programming+Languages#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Pargyline",
"description": "Quelles sont les complications possibles de la pargyline ?\nComment gérer une hypertension causée par la pargyline ?\nLa pargyline peut-elle entraîner des troubles psychologiques ?\nQuels signes indiquent une complication grave de la pargyline ?\nComment prévenir les complications liées à la pargyline ?",
"url": "https://questionsmedicales.fr/mesh/D010293?mesh_terms=Programming+Languages#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Pargyline",
"description": "Quels facteurs augmentent le risque d'effets secondaires de la pargyline ?\nLes antécédents d'AVC sont-ils un facteur de risque pour la pargyline ?\nLe diabète est-il un facteur de risque pour la pargyline ?\nLes femmes enceintes doivent-elles éviter la pargyline ?\nQuels médicaments augmentent le risque d'interactions avec la pargyline ?",
"url": "https://questionsmedicales.fr/mesh/D010293?mesh_terms=Programming+Languages#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une surdose de pargyline ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur les symptômes cliniques et l'historique médicamenteux."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'effet de la pargyline ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de pression artérielle et des évaluations neurologiques sont courants."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de pargyline ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes de la maladie de Parkinson, comme les tremblements et la rigidité, sont indicatifs."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité de la pargyline ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par l'amélioration des symptômes moteurs et de la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques nécessitent un ajustement de dose ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes d'hypertension ou d'effets secondaires neurologiques peuvent nécessiter un ajustement."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants de la pargyline ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des maux de tête, des vertiges et des nausées."
}
},
{
"@type": "Question",
"name": "La pargyline peut-elle causer des troubles du sommeil ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles du sommeil comme l'insomnie peuvent survenir avec la pargyline."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une réaction allergique à la pargyline ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, des démangeaisons ou un gonflement peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "La pargyline peut-elle provoquer des palpitations ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des palpitations cardiaques peuvent être un effet secondaire de la pargyline."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une consultation médicale urgente ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des difficultés respiratoires ou des symptômes neurologiques graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets secondaires de la pargyline ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un ajustement de la dose peuvent aider à prévenir les effets secondaires."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre avant de commencer la pargyline ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informez votre médecin de vos antécédents médicaux et des médicaments en cours."
}
},
{
"@type": "Question",
"name": "La pargyline nécessite-t-elle un régime alimentaire particulier ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est conseillé d'éviter les aliments riches en tyramine pour prévenir les interactions."
}
},
{
"@type": "Question",
"name": "Comment éviter les interactions médicamenteuses avec la pargyline ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Discutez toujours avec votre médecin avant d'ajouter un nouveau médicament à votre traitement."
}
},
{
"@type": "Question",
"name": "Quels conseils donner aux patients sous pargyline ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informez-vous sur les effets secondaires et signalez tout symptôme inhabituel à votre médecin."
}
},
{
"@type": "Question",
"name": "Comment la pargyline est-elle administrée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pargyline est généralement administrée par voie orale sous forme de comprimés."
}
},
{
"@type": "Question",
"name": "La pargyline peut-elle être combinée avec d'autres médicaments ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il faut éviter les autres IMAO et certains antidépresseurs pour prévenir les interactions."
}
},
{
"@type": "Question",
"name": "Quel est le dosage habituel de pargyline ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dosage habituel commence souvent à 10 mg par jour, ajusté selon la réponse clinique."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements alternatifs à la pargyline ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "D'autres IMAO ou médicaments dopaminergiques peuvent être envisagés comme alternatives."
}
},
{
"@type": "Question",
"name": "Comment surveiller les effets de la pargyline ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance inclut des contrôles réguliers de la pression artérielle et des évaluations neurologiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la pargyline ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'hypertension, les troubles neurologiques et les réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment gérer une hypertension causée par la pargyline ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est crucial de consulter un médecin pour ajuster le traitement et surveiller la pression."
}
},
{
"@type": "Question",
"name": "La pargyline peut-elle entraîner des troubles psychologiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme l'anxiété ou la dépression peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave de la pargyline ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes tels que des douleurs thoraciques ou des troubles de la vision nécessitent une attention immédiate."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées à la pargyline ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier et une communication ouverte avec le médecin sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'effets secondaires de la pargyline ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies cardiovasculaires et la prise d'autres médicaments augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents d'AVC sont-ils un facteur de risque pour la pargyline ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents d'AVC peuvent augmenter le risque de complications avec la pargyline."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque pour la pargyline ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut augmenter le risque d'effets indésirables lors de l'utilisation de pargyline."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles éviter la pargyline ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la pargyline est généralement contre-indiquée pendant la grossesse en raison des risques potentiels."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque d'interactions avec la pargyline ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antidépresseurs, les autres IMAO et certains analgésiques peuvent augmenter ce risque."
}
}
]
}
]
}
MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, Fujian Provincial Key Laboratory of Electrochemical Energy Storage Materials, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China. qhw76@fzu.edu.cn.
MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, Fujian Provincial Key Laboratory of Electrochemical Energy Storage Materials, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China. qhw76@fzu.edu.cn.
MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, Fujian Provincial Key Laboratory of Electrochemical Energy Storage Materials, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China. qhw76@fzu.edu.cn.
MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, Fujian Provincial Key Laboratory of Electrochemical Energy Storage Materials, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China. qhw76@fzu.edu.cn.
MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, Fujian Provincial Key Laboratory of Electrochemical Energy Storage Materials, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China. qhw76@fzu.edu.cn.
MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, Fujian Provincial Key Laboratory of Electrochemical Energy Storage Materials, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China. qhw76@fzu.edu.cn.
State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, China.
Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110031, Taiwan.
TMU Research Center of Drug Discovery, Taipei Medical University, Taipei 110031, Taiwan.
Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 110031, Taiwan.
Master Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110031, Taiwan.
Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110031, Taiwan.
TMU Research Center of Drug Discovery, Taipei Medical University, Taipei 110031, Taiwan.
Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 110031, Taiwan.
The Biology System Description Language (BiSDL) is an accessible, easy-to-use computational language for multicellular synthetic biology. It allows synthetic biologists to represent spatiality and mul...
BiSDL's effectiveness is showcased through three case studies on complex multicellular systems: a bacterial consortium, a synthetic morphogen system and a conjugative plasmid transfer process. These s...
BiSDL represents a significant step forward in computational languages for synthetic biology, providing a sophisticated yet user-friendly tool for designing and simulating complex biological systems w...
Language models are playing an increasingly important role in many areas of artificial intelligence (AI) and computational biology. In this primer, we discuss the ways in which language models, both t...
The target article claims that we should speak in code to understand property, because natural language is too ambiguous. Yet the best computer programmers tell us the opposite: Arbitrary code is too ...
The increased demand for efficient computation in data analysis encourages researchers in biomedical science to use workflow systems. Workflow systems, or so-called workflow languages, are used for th...
Reaching meaningful interoperability between proprietary health care systems is a ubiquitous task in medical informatics, where communication servers are traditionally used for referring and transform...
In this study, a generic approach is developed, which allows for the application of declarative mapping rules defined using FML in an exchangeable manner. A transformation engine is required to execut...
FHIR natively defines resources to support the conversion of instance data, such as an FHIR StructureMap. This resource encodes all information required to transform data from a source system to a tar...
The resulting tool is called FML2Mirth, a Java-based transformer that derives Mirth channels from detailed declarative mapping rules based on the underlying StructureMaps. Implementation of the transl...
The tool for the auto-generation of Mirth channels was successfully presented. Our tests reveal the feasibility of using the complex structures of the mapping language in combination with a terminolog...
To present findings from an evaluation of the Spanish Language Track (SLT) for student pharmacists, which assessed student outcomes and feedback....
A mixed-methods program evaluation was conducted with the first cohort of the SLT members (N = 10). Participants completed pre/post-surveys and focus groups. Quantitative data analysis employed descri...
With a focus on qualitative themes, quantitative results support themes one, two, and three based on findings from the self-assessment of participants' ability to speak and use the Spanish Language. F...
Findings demonstrate students' active engagement with SLT while enhancing language skills through immersive experiences. Their connections with other cohort members, SLT team members, Colombian pharma...
Does the perisylvian language network contribute to comprehension of programming languages, like Python? Univariate neuroimaging studies find high responses to code in fronto-parietal executive areas ...
Linguistic inequity drives systemic disparities in healthcare for non-native English speakers. This study evaluates a project to train and provide qualified medical interpreters (QMI) to assist volunt...
Continual technological advances associated with the recent automation revolution have tremendously increased the impact of computer technology in the industry. Software development and testing are ti...